Keith G. Phillips
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
TRPA1 Antagonist LY3526318 Inhibits the Cinnamaldehyde-Evoked Dermal Blood Flow Increase: Translational Proof of Pharmacology.
Journal: Clinical pharmacology and therapeutics
Published: April 19, 2023
Critical thinking in musicians' health education. Findings from four workshops with experts (Part I).
Journal: Health promotion international
Published: March 14, 2023
Correction: Impaired speed encoding and grid cell periodicity in a mouse model of tauopathy.
Journal: eLife
Published: March 07, 2023
The test-retest reliability of large and small fiber nerve excitability testing with threshold tracking.
Journal: Clinical neurophysiology practice
Published: February 02, 2023
Health education in conservatoires: what should it consist of? Findings from workshops with experts (Part II).
Journal: Health promotion international
Published: January 08, 2023
Erratum to "How different experimental models of secondary hyperalgesia change the nociceptive flexion reflex" [Clin. Neurophysiol. 132 (2021) 2989-2995].
Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Published: November 10, 2022
Erratum to 'The N13 spinal component of somatosensory evoked potentials is modulated by heterotopic noxious conditioning stimulation suggesting an involvement of spinal wide dynamic range neurons'.
Journal: Neurophysiologie clinique = Clinical neurophysiology
Published: October 09, 2022
Pharmacological Probes to Validate Biomarkers for Analgesic Drug Development.
Journal: International journal of molecular sciences
Published: June 16, 2022
Altered low-frequency brain rhythms precede changes in gamma power during tauopathy.
Journal: iScience
Published: May 13, 2022
IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity.
Journal: Trials
Published: December 06, 2021
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET).
Journal: Trials
Published: September 08, 2021
Last Updated: 09/26/2026